Volitionrx Limited (VNRX) to Offer Common Stock

VolitionRx Limited (NYSE: VNRX) announced today that it is commencing an underwritten public offering of its common stock (the "Offering"). All of the shares to be sold in the Offering will be sold by Volition, subject to customary closing conditions. In addition, Volition intends to grant the underwriter for the Offering a 30-day option to purchase up to an additional 15% of the number of shares of its common stock offered in the Offering.

Cantor Fitzgerald & Co. is acting as the sole book running manager of the Offering.

You May Also Be Interested In

• Q32 Bio prices $200 million stock offering at $18.25 per share
• Terawulf (WULF) Reiterated at Overweight by Cantor Fitzgerald After Data Center Moratorium
• Cantor Fitzgerald Reiterates Neutral Rating on Camtek (CAMT) as Competitive Risks Persist